Z
Zenas Biopharma Inc
NASDAQ:ZBIO
Zenas Biopharma Inc
NASDAQ:ZBIO
Price:
22.19
USD
5.37%
Market Closed
Market Cap:
$1.2B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Z
|
Zenas Biopharma Inc
NASDAQ:ZBIO
|
US |
|
Shenzhen Soling Industrial Co Ltd
SZSE:002766
|
CN |
|
NCAB Group AB (publ)
STO:NCAB
|
SE |
|
D
|
Deportes Club de Golf Santiago SA
SGO:GOLF
|
CL |
|
Suminoe Textile Co Ltd
TSE:3501
|
JP |
Income Statement
Earnings Waterfall
Zenas Biopharma Inc
Zenas Biopharma Inc
Income Statement
Zenas Biopharma Inc
Zenas Biopharma Inc
Currency: USD
| Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||
| Interest Expense |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
|
| Revenue |
50
N/A
|
50
N/A
|
50
N/A
|
50
N/A
|
0
N/A
|
5
N/A
|
15
+200%
|
15
N/A
|
15
N/A
|
|
| Operating Income | ||||||||||
| Operating Expenses |
(71)
|
(77)
|
(96)
|
(106)
|
(133)
|
(169)
|
(189)
|
(204)
|
(211)
|
|
| Selling, General & Administrative |
(16)
|
(17)
|
(18)
|
(20)
|
(23)
|
(30)
|
(37)
|
(43)
|
(49)
|
|
| Research & Development |
(55)
|
(60)
|
(67)
|
(86)
|
(110)
|
(139)
|
(151)
|
(161)
|
(162)
|
|
| Other Operating Expenses |
0
|
0
|
(10)
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Operating Income |
(21)
N/A
|
(27)
-27%
|
(46)
-68%
|
(56)
-24%
|
(133)
-136%
|
(164)
-23%
|
(174)
-6%
|
(189)
-9%
|
(196)
-3%
|
|
| Pre-Tax Income | ||||||||||
| Interest Income Expense |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(2)
|
|
| Non-Reccuring Items |
(10)
|
(10)
|
0
|
0
|
0
|
0
|
0
|
0
|
(5)
|
|
| Total Other Income |
(0)
|
0
|
0
|
2
|
4
|
7
|
11
|
12
|
13
|
|
| Pre-Tax Income |
(32)
N/A
|
(37)
-17%
|
(46)
-24%
|
(54)
-20%
|
(129)
-136%
|
(157)
-22%
|
(163)
-4%
|
(177)
-9%
|
(190)
-7%
|
|
| Net Income | ||||||||||
| Tax Provision |
0
|
(0)
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Income from Continuing Operations |
(32)
|
(37)
|
(46)
|
(55)
|
(129)
|
(157)
|
(163)
|
(177)
|
(190)
|
|
| Net Income (Common) |
(32)
N/A
|
(37)
-18%
|
(46)
-23%
|
(55)
-19%
|
(129)
-136%
|
(157)
-22%
|
(163)
-4%
|
(177)
-9%
|
(190)
-7%
|
|
| EPS (Diluted) |
-0.8
N/A
|
-0.93
-16%
|
-1.16
-25%
|
-1.38
-19%
|
-3.08
-123%
|
-11.89
-286%
|
-3.89
+67%
|
-4.22
-8%
|
-4.5
-7%
|
|
Switch to:
Switch to:
See Also
Discover More
